Evaluation of Risk Markers Fluctuation During an Initial Therapy With Rosiglitazon in Patients Suffering from Metabolic Syndrome. Biomol Biomed 2009, 9 (4), 320-328. https://doi.org/10.17305/bjbms.2009.2788.